August 20, 2019 – The U.S. Preventive Services Task Force released today a final recommendation statement on risk assessment, genetic counseling, and genetic testing for BRCA1/2-related cancer. The Task Force found that some women may benefit from risk assessment, counseling, and testing for the rare genetic mutation. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the August 20, 2019 online issue of JAMA.
